Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy ; day:6 ; month:1 ; year:2020 ; pages:1-10
European archives of psychiatry and clinical neuroscience ; (6.1.2020), 1-10
- Creator
-
Vierke, Christopher
Marxen, Brigitte
Boettcher, Michael
Hiemke, Christoph
Havemann-Reinecke, Ursula
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-019-01091-0
- URN
-
urn:nbn:de:101:1-2020041310101138310691
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vierke, Christopher
- Marxen, Brigitte
- Boettcher, Michael
- Hiemke, Christoph
- Havemann-Reinecke, Ursula
- SpringerLink (Online service)
Other Objects (12)
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series